| HOME >> BIOLOGY >> TECHNOLOGY |
10,684
(4)
30,779Non-GAAP Income Tax Provision Adjustments:Income tax adjustments
(170,681)(157,490)Total Non-GAAP Income Tax Provision Adjustments
(170,681)
(5)
(157,490)Non-GAAP Net Income$
713,625$
88,921Non-GAAP loss attributable to non-controlling interest
406
(6)
350Non-GAAP Net Income Attributable to Controlling Interest$
714,031$
89,271Add back interest expense for subordinated debt, net of tax
12131Non-GAAP Numerator for diluted earnings per share$
714,043$
89,402Non-GAAP Earnings per common share:Basic earnings per share attributable to controlling interest$
4.06$
3.84Diluted earnings per share attributable to controlling interest$
3.98$
3.71Weighted average shares used in per share calculation:Basic175,831179,390Diluted179,365185,595Summary of Reconciliation between GAAP and Non-GAAP Net IncomeFor the year ended December 31, 2012, Non-GAAP earnings resulted in total revenue of $3.8 billion, gross profit of $2.5 billion with gross margin of 65.6%, operating profit of $1.1 billion with operating margin of 29.2%, and an income tax provision of $272.1 million with the Non-GAAP effective tax rate of 27.6% with the above adjustments.For the year ended December 31, 2011, Non-GAAP earnings resulted in total revenue of $3.7 billion, gross profit of $2.4 billion with gross margin of 65.2%, operating profit of $1.1 billion with operating margin of 29.0%, and an income tax provision of $258.4 million with the Non-GAAP effective tax rate of 27.3% with the above adjustments.Notes(1)
Add back purchased deferred revenue of $1.3 million and adjust for revenue related to a discontinued product of $0.5 million for the year ended December 31, 2012. Add back purchased deferred revenue of $2.9 million and revenue relat
'/>"/>
| SOURCE Life Technologies Corporation Copyright©2012 PR Newswire. All rights reserved |